Exscientia plc is a pharmatech that offers end-to-end AI-enabled technologies for target identification, drug candidate design, translational models, and patient selection. Its platform enables the design of candidate drug molecules, as well as provides patients with drug therapies through AI-guided assessment. Exscientia was founded in 2012 and is headquartered in Oxford, UK.